Literature DB >> 19504103

Parametric exploration of the liver by magnetic resonance methods.

Paul E Sijens1.   

Abstract

MRI, as a completely noninvasive technique, can provide quantitative assessment of perfusion, diffusion, viscoelasticity and metabolism, yielding diverse information about liver function. Furthermore, pathological accumulations of iron and lipids can be quantified. Perfusion MRI with various contrast agents is commonly used for the detection and characterization of focal liver disease and the quantification of blood flow parameters. An extended new application is the evaluation of the therapeutic effect of antiangiogenic drugs on liver tumours. Novel, but already widespread, is a histologically validated relaxometry method using five gradient echo sequences for quantifying liver iron content elevation, a measure of inflammation, liver disease and cancer. Because of the high perfusion fraction in the liver, the apparent diffusion coefficients strongly depend on the gradient factors used in diffusion-weighted MRI. While complicating analysis, this offers the opportunity to study perfusion without contrast injection. Another novel method, MR elastography, has already been established as the only technique able to stage fibrosis or diagnose mild disease. Liver fat content is accurately determined with multivoxel MR spectroscopy (MRS) or by faster MRI methods that are, despite their widespread use, prone to systematic error. Focal liver disease characterisation will be of great benefit once multivoxel methods with fat suppression are implemented in proton MRS, in particular on high-field MR systems providing gains in signal-to-noise ratio and spectral resolution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504103      PMCID: PMC2762052          DOI: 10.1007/s00330-009-1470-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  108 in total

1.  Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging.

Authors:  Roy Irwan; Mireille A Edens; Paul E Sijens
Journal:  Eur Radiol       Date:  2007-11-13       Impact factor: 5.315

2.  Noninvasive assessment of the rheological behavior of human organs using multifrequency MR elastography: a study of brain and liver viscoelasticity.

Authors:  Dieter Klatt; Uwe Hamhaber; Patrick Asbach; Jürgen Braun; Ingolf Sack
Journal:  Phys Med Biol       Date:  2007-11-23       Impact factor: 3.609

3.  Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique.

Authors:  Melanie Bruegel; Konstantin Holzapfel; Jochen Gaa; Klaus Woertler; Simone Waldt; Berthold Kiefer; Alto Stemmer; Carl Ganter; Ernst J Rummeny
Journal:  Eur Radiol       Date:  2007-10-25       Impact factor: 5.315

4.  Diffusion-weighted imaging in the differential diagnosis of simple and hydatid cysts of the liver.

Authors:  Nagihan Inan; Arzu Arslan; Gur Akansel; Yonca Anik; H Tahsin Sarisoy; Ercument Ciftci; Ali Demirci
Journal:  AJR Am J Roentgenol       Date:  2007-11       Impact factor: 3.959

5.  Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions.

Authors:  Sofia Gourtsoyianni; Nickolas Papanikolaou; Spyros Yarmenitis; Thomas Maris; Apostolos Karantanas; Nicholas Gourtsoyiannis
Journal:  Eur Radiol       Date:  2007-11-10       Impact factor: 5.315

6.  Hepatic viscoelastic parameters measured with MR elastography: correlations with quantitative analysis of liver fibrosis in the rat.

Authors:  Najat Salameh; Frank Peeters; Ralph Sinkus; Jorge Abarca-Quinones; Laurence Annet; Leon C Ter Beek; Isabelle Leclercq; Bernard E Van Beers
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

7.  Assessment of hepatic fibrosis with magnetic resonance elastography.

Authors:  Meng Yin; Jayant A Talwalkar; Kevin J Glaser; Armando Manduca; Roger C Grimm; Phillip J Rossman; Jeff L Fidler; Richard L Ehman
Journal:  Clin Gastroenterol Hepatol       Date:  2007-10       Impact factor: 11.382

8.  Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index.

Authors:  Laurent Huwart; Christine Sempoux; Najat Salameh; Jacques Jamart; Laurence Annet; Ralph Sinkus; Frank Peeters; Leon C ter Beek; Yves Horsmans; Bernard E Van Beers
Journal:  Radiology       Date:  2007-11       Impact factor: 11.105

9.  comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major.

Authors:  Vassilios Perifanis; Athanasios Christoforidis; Efthimia Vlachaki; Ioanna Tsatra; George Spanos; Miranda Athanassiou-Metaxa
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

10.  Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.

Authors:  Mari Hagiwara; Henry Rusinek; Vivian S Lee; Mariela Losada; Michael A Bannan; Glenn A Krinsky; Bachir Taouli
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

View more
  15 in total

1.  Liver magnetic resonance imaging: State of the art.

Authors:  Paul E Sijens
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

2.  Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging.

Authors:  James T Lee; Joy Liau; Paul Murphy; Michael E Schroeder; Claude B Sirlin; Mark Bydder
Journal:  Magn Reson Imaging       Date:  2012-01-27       Impact factor: 2.546

3.  MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide.

Authors:  Qing-Bing Wang; Yu Han; Ting-Ting Jiang; Wei-Min Chai; Ke-Min Chen; Bing-Ya Liu; Li-Fu Wang; Chunfu Zhang; Deng-Bin Wang
Journal:  Eur Radiol       Date:  2010-10-25       Impact factor: 5.315

Review 4.  Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.

Authors:  Pieter C Dagnelie; Susanne Leij-Halfwerk
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 5.  Liver fat content determined by magnetic resonance imaging and spectroscopy.

Authors:  Fabian Springer; Jürgen Machann; Claus D Claussen; Fritz Schick; Nina F Schwenzer
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

6.  Assessment of relevant hepatic steatosis in obese adolescents by rapid fat-selective GRE imaging with spatial-spectral excitation: a quantitative comparison with spectroscopic findings.

Authors:  Fabian Springer; Stefan Ehehalt; Julia Sommer; Verena Ballweg; Jürgen Machann; Gerhard Binder; Claus D Claussen; Fritz Schick
Journal:  Eur Radiol       Date:  2010-10-03       Impact factor: 5.315

Review 7.  Perfusion magnetic resonance imaging of the liver.

Authors:  Choon Hua Thng; Tong San Koh; David J Collins; Dow Mu Koh
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 8.  The Clinical Implications of Fatty Pancreas: A Concise Review.

Authors:  Tawfik Khoury; Akwi W Asombang; Tyler M Berzin; Jonah Cohen; Douglas K Pleskow; Meir Mizrahi
Journal:  Dig Dis Sci       Date:  2017-08-08       Impact factor: 3.199

9.  Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Michele Di Martino; Caterina Anania; Gian Marco Andreoli; Mario Bezzi; Carlo Catalano; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

10.  3.0 T proton magnetic resonance spectroscopy of the liver: quantification of choline.

Authors:  Li Xu; Bo Liu; Yan Huang; Xian Liu; Si-Wei Zhang; Xue-Gang Xin; Jin-Zhi Zheng
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.